Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Treasury Shares (2021 - 2025)

GeneDx Holdings has reported Treasury Shares over the past 5 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Treasury Shares at $1.5 million for Q4 2025, down 18.71% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 18.71% YoY), and the annual figure for FY2025 was $1.5 million, down 18.71%.
  • Treasury Shares for Q4 2025 was $1.5 million at GeneDx Holdings, down from $1.6 million in the prior quarter.
  • Over the last five years, Treasury Shares for WGSWW hit a ceiling of $23.7 million in Q3 2022 and a floor of $855061.0 in Q4 2022.
  • Median Treasury Shares over the past 5 years was $1.9 million (2024), compared with a mean of $5.5 million.
  • Biggest five-year swings in Treasury Shares: plummeted 93.21% in 2022 and later skyrocketed 76.35% in 2023.
  • GeneDx Holdings' Treasury Shares stood at $12.6 million in 2021, then plummeted by 93.21% to $855061.0 in 2022, then skyrocketed by 76.35% to $1.5 million in 2023, then grew by 23.99% to $1.9 million in 2024, then fell by 18.71% to $1.5 million in 2025.
  • The last three reported values for Treasury Shares were $1.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.